Amgen agrees to $74M settlement to resolve investor lawsuit over potential $10.7B tax bill

Amgen has agreed to a $74 million settlement with investors to resolve a lawsuit that alleged the company hid a $10.7 billion tax bill from the public and kept the company's share price artificially high from July of 2020 to April of 2022.

Source: FiercePharma